Day: September 7, 2021

        Press releaseMalmö, Sweden, September 7, 2021 New health economic study proves the value of CADScor® in coronary disease diagnostics A peer-reviewed publication in the September 2021 edition of PharmacoEconomics shows an estimated 12.3£ million savings to the English health care system per 100,000 eligible patients when using the Acarix CADScor system to rule out coronary artery disease (CAD). Coronary artery disease (CAD) is the most common heart and circulatory disease and is the leading cause of death worldwide. The current diagnostic pathway for CAD is costly, time consuming and for up to 90% of patients the tests are unnecessary. The Acarix CADScor system is a CE and FDA-cleared device to enable highly accurate early rule-out of CAD using acoustic detection before patients undergo invasive diagnostic procedures. The authors...

MCCARRAN, Nev., Sept. 07, 2021 (GLOBE NEWSWIRE) — Aqua Metals, Inc. (NASDAQ: AQMS) (“Aqua Metals” or the “Company”), which is reinventing metals recycling with its AquaRefining™ technology, announced today the Company will participate in the 23rd Annual H.C. Wainwright Global Investment Conference. Aqua Metal’s Chief Executive Officer, Steve Cotton, is scheduled to present via webcast and will also be available for one-on-one meetings with investors. The webcast presentation will be available on September 13th at 7:00 a.m. EST and will be archived for 90 days. Interested parties may access the webcast and listen to the presentation through the following link: https://journey.ct.events/view/4a13dfe1-0134-4346-a236-868fb834f197 About Aqua Metals Aqua Metals, Inc. (NASDAQ: AQMS) is reinventing metals recycling with its patented...

Claymont, DE, Sept. 07, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Golden Star Enterprises Ltd., (OTCPink: GSPT) reports today that its wholly-owned subsidiary, Enigmai, has signed an agreement with the City of Tel-Aviv, Israel for the city to test their Enigmai Business Suite (EBS) software in a pilot program. The terms of the agreement include the provision of Enigmai’s EBS software for a two-month pilot program with the City of Tel Aviv, during which time the city’s call center team will test the innovative Workforce Management product. In preliminary conversations with city representatives, there has been a high level of interest in the Enigmai product and its capabilities. Eital Muskal, VP of Strategy and Business Development, said, “I am excited for the opportunity to start a relationship with the City of Tel...

GREENWICH, Conn., Sept. 07, 2021 (GLOBE NEWSWIRE) — Oxford Lane Capital Corp. (the “Company”) (NasdaqGS: OXLC, OXLCM, OXLCO, OXLCP and OXLCL) today announced the following net asset value (“NAV”) estimate as of August 31, 2021.Management’s unaudited estimate of the range of the NAV per share of our common stock as of August 31, 2021 is between $6.69 and $6.79. This estimate is not a comprehensive statement of our financial condition or results for the month ended August 31, 2021. This estimate did not undergo the Company’s typical quarter-end financial closing procedures and was not approved by the Company’s board of directors. We advise you that our NAV per share for the quarter ending September 30, 2021 may differ materially from this estimate, which is given only as of August 31, 2021.As of August 31, 2021, the Company had...

SEATTLE, Sept. 07, 2021 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced that Jonathan Drachman, M.D., Chief Executive Officer, will present a corporate overview during the H.C. Wainwright 23rd Annual Global Life Sciences Conference taking place September 13-15, 2021. A pre-recorded presentation will be available for on-demand access beginning at 7:00 am ET on Monday, September 13, 2021 from the investors section of the Neoleukin website at http://investor.neoleukin.com/events. An archived replay will also be available on the company website for at least 30 days following the event. About Neoleukin Therapeutics, Inc. Neoleukin is a biopharmaceutical company creating next generation...

CAMBRIDGE, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that members of management will present at three upcoming investor conferences. Details are as follows:Baird 2021 Global Healthcare ConferenceFormat: Fireside ChatDate/Time: Tuesday, September 14, 2021, at 8:30 a.m. ET   Morgan Stanley 19th Annual Global Healthcare ConferenceFormat: Fireside ChatDate/Time: Wednesday, September 15, 2021, at 1:15 p.m. ET   2021 Cantor Virtual Global Healthcare ConferenceFormat: PresentationDate/Time: Tuesday, September 28, 2021, at 4:00 p.m. ETA live webcast of these events...

Eatontown, NJ, Sept. 07, 2021 (GLOBE NEWSWIRE) — Investview, Inc. (OTCQB: INVU), a diversified financial technology company that through its subsidiaries and global distribution network provides financial technology, education tools, content, research, and management of digital asset technologies with a focus on Bitcoin mining and the new generation of digital assets, announces its production and operational updates, including its unaudited Bitcoin (“BTC“) production for August 2021. August 2021 BTC Production and Digital Asset HoldingsGross Revenue of $3.1 million, up 238% Year-Over-Year August Gross Profit of $2.5 million, up 561% Year-Over-Year August Gross Profit Margin of 80% Bitcoin Mined over 16 months period ending August 2021, 1,072.43 Bitcoin As of August 31, 2021, Investview holds over 146.38 BTC As of August 31, 2021,...

SAN DIEGO and SHANGHAI, China, Sept. 07, 2021 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that NuProbe Global, a global molecular diagnostics company based in Shanghai, China and Houston, Texas, has adopted Bionano’s Saphyr system for optical genome mapping (OGM) to integrate their Quantitative Amplicon Sequencing (QASeq) and Blocker Displacement Amplification (BDA) technologies for research and product development in the fields of reproductive health and oncology liquid biopsies. “The Bionano OGM system provides direct and unambiguous identification and characterization of large-scale DNA structural variants without complex bioinformatics. NuProbe’s BDA technology helps zoom in on low frequency variants with single-base resolution. We believe this combination can provide genomics and clinical...

New cloud compliance, operator productivity, and cloud deployment capabilities help teams accelerate their DevOps journeys BEDFORD, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) — Progress (NASDAQ: PRGS), the leading provider of products to develop, deploy and manage high-impact business applications, today announced the availability of enhancements to the Progress® Chef® portfolio that span multi-cloud trust and compliance, operator experience and productivity, and cloud “as a service” deployment flexibility. Progress will highlight these capabilities at ChefConf℠ 2021, the virtual version of its 10th annual Chef community and user conference held today through September 9, with a focus on helping teams accelerate their DevOps journeys. “Rapid and continuous delivery of secure infrastructure and applications is critical to business agility...

WARMINSTER, Pa., Sept. 07, 2021 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on discovering, developing and commercializing a cure for people with chronic hepatitis B virus (HBV) infection, as well as therapies to treat coronaviruses (including COVID-19), today announced that the Company will participate in the following upcoming virtual investor conferences: H.C. Wainwright 23rd Annual Global Investment Conference (September 13-15, 2021)Fireside Chat: available starting at 7:00 am ET on Monday, September 13, 2021 Presenters: William Collier, President and Chief Executive Officer; Dr. Michael Sofia, Chief Scientific Officer; Dr. Gaston Picchio, Chief Development Officer; and David Hastings, Chief Financial Officer Webcast LinkCantor Global Healthcare...